TSH and Free T4: A Signal and a Hormone

TSH and free T4 describe different parts of thyroid regulation. TSH is a signal from the pituitary gland. T4 is a hormone made by the thyroid. The word “free” identifies the portion of T4 that is not attached to binding proteins.

Read the labels before the arrows

Total T4 and free T4 are not merely two spellings of the same assay. Binding proteins can change in circumstances such as pregnancy or with certain medicines, which is one reason the exact measurement matters.

The gland named in a test is not always the gland producing it

The name thyroid-stimulating hormone describes what TSH does: it signals the thyroid. It does not mean that the thyroid produces TSH. The pituitary produces the signal, while the thyroid produces thyroid hormones such as T4. Keeping the source and destination separate makes the relationship easier to understand.

A useful analogy is a request sent to a production system. The request and the output are related, but they are not the same item. Measuring the request can provide information about how the system is being regulated; measuring the output provides another view. The analogy is only a way to distinguish roles, not a diagnostic model of a person's endocrine system.

In the usual feedback relationship, thyroid-hormone availability influences pituitary signaling. That relationship helps explain why TSH and a thyroid hormone may be considered together. It does not mean that every real-world result can be interpreted from one simple pair of arrows.

Free and total change which portion is measured

Most T4 in circulation is attached to proteins. Total T4 includes bound and unbound hormone; free T4 refers to the unbound portion. The word free therefore describes binding status. It is not a claim that the assay is a more complete measure of every thyroid-related process.

Changes in binding proteins can affect how total-hormone measurements are interpreted. NIDDK describes pregnancy and certain medicines as examples of contexts that can change the relationship. The appropriate assay and interpretation depend on the clinical question, so the definitions do not establish that everyone needs both measurements.

Imagine a fictional record that lists total T4 in January and free T4 in April. Shortening both entries to T4 makes the record appear simpler but removes the difference that matters. A line drawn between those values is not a trend in one measurement. Even a unit conversion cannot turn bound-plus-unbound hormone into the unbound portion.

The same problem can occur when copying information into a message. “My thyroid level changed” does not identify whether the result was TSH, total T4, free T4, or another test. The complete label is the starting point for a useful discussion.

Thyroid antibodies ask a different question again

NIDDK explains that antibody tests can help investigate autoimmune thyroid conditions in an appropriate setting. These tests look for immune-related evidence rather than measuring the concentration of TSH or T4. They should not be placed on the same graph as though all were successive readings of one thyroid quantity.

Imaging also provides a different kind of information. A picture of the thyroid is not a blood hormone measurement, and a hormone measurement does not describe every structural feature of the gland. Several tests can contribute to an evaluation while retaining distinct purposes.

This is the general distinction between screening, diagnosis, and monitoring. A test used to follow an established treatment plan may answer a different question from a test used to investigate a new concern. The panel's marketing name cannot establish that purpose.

Why they may be considered together

A feedback system links the pituitary and thyroid. Measuring the signal and a thyroid hormone can provide more context than looking at either label alone. Clinicians may also use other tests when they need to investigate the cause of an abnormal finding.

This relationship should not be reduced to a universal two-arrow diagnosis chart. Illness, treatment, pregnancy, laboratory methods, and less common clinical situations can complicate interpretation. The table identifies measurements; it does not tell you how to change a prescription.

An unexpected result can require a method question

Not every unexpected number is explained by a change in hormone production. Some substances can interfere with particular laboratory methods. NIH's Office of Dietary Supplements describes biotin interference in certain thyroid assays as an example. The possibility depends on the method and circumstances; it is not a claim that every thyroid result is affected.

For that reason, tell the care team about supplements as well as prescription and nonprescription medicines. If the result does not fit the clinical picture, the clinician and laboratory can consider whether interference or another explanation is relevant. Do not assume interference proves that an unwanted result is false.

This article does not provide a universal supplement-stopping interval. The product, amount, timing, assay, and reason for use can matter. Follow specific professional instructions rather than changing a regimen to try to produce a preferred number.

When comparing reports, retain collection dates, exact assay labels, units, and comments. Keep the laboratory interval separate from a care goal. These details help the clinician distinguish a reporting difference, a contextual difference, and a meaningful change that needs follow-up.

Three checks when reading a report

First, confirm whether the report says free or total T4. Second, keep each value with its own units and laboratory interval. Third, note whether the test was performed during treatment or for an initial investigation.

Thyroid blood tests usually use a venous sample. Discuss medicines and supplements with the ordering clinician, and follow instructions for the full order. If a result seems inconsistent with symptoms or an earlier report, ask for an explanation rather than choosing a reference range from another website.